PReCIOUS: the new project begins

August 1, 2018, sees the official launch of the PReCIOUS project, financed by the Friuli Venezia Giulia Autonomous Region in the context of the 2014-2020 POR-FESR funds (activity 1.2.a.1) for a grant of € 95.491,28. The project is divided into three successive stages: set-up, tune-up, and validation. The set-up phase, which will last one quarter,

oraCle – New year press releases

The local and national press is talking about “oraCle: New integrated approach for the oral therapy of Crohn’s disease”. Many journals are spreading awareness towards this project. Here the press releases issued in the month of January, 2018. Diario di Udine 03 gennaio 2018 [ITA] Il 03 gennaio 2018 [ITA] Messaggero 03 gennaio 2018 [ITA] Messaggero

oraCle – 3rd project meeting

The oraCle project is at the height of its activities. The scientific partners met at the University of Trieste, guests of the Department of Life Sciences, on October 12, 2017. For the purposes of a better and more effective sharing of the respective contributions, each partner has structured a presentation of its research activities, highlighting

oraCle – 2nd project meeting

The oraCle project is proceeding well. The project partners met in the second meeting, held on 19 June 2017 at the Biofarma SpA headquarters. The meeting, focused on the scientific side of oraCle, saw a useful confrontation on the technical aspects and the definition of the planned activities for the coming months. On the agenda: Any

The “oraCle” project ranks first – approved for funding

In July 2017 Transactiva directed, as leader, a public-private partnership for the participation in the POR FESR 2014-2020 calls, (Activity 1.3.b) – for “R&D projects to be achieved through public-private partnerships – areas of specialization Maritime Technologies and Smart Health”. The project “A new integrated approach for oral therapy of Crohn’s disease: oraCle” was presented